Pharmaceutical Price Regulation in the Theory of Redistribution Systems

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216275%3A25410%2F14%3A39899142" target="_blank" >RIV/00216275:25410/14:39899142 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.slu.cz/opf/cz/informace/acta-academica-karviniensia/casopisy-aak/aak-rocnik-2014/docs-2-2014/Svatosova_Zahour_Kosnarova_Sekerka.pdf" target="_blank" >http://www.slu.cz/opf/cz/informace/acta-academica-karviniensia/casopisy-aak/aak-rocnik-2014/docs-2-2014/Svatosova_Zahour_Kosnarova_Sekerka.pdf</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Pharmaceutical Price Regulation in the Theory of Redistribution Systems

Popis výsledku v původním jazyce

Nowadays, a firm has to, not only, follow the outside environment and predominantly its field environment where it constantly maps customers' behaviour, but the firm has to also perceive the inside environment. Firm price making represents the key role.This paper describes pharmaceutical market and its rules of price making. As remedies should be available to anyone, it is obvious that the market is regulated by state. Products are divided into groups according to their prices. The groups are identified by the highest possible percentage of margin that can be made by a particular product. On the basis of publicly available data this paper analyses behaviour of producers and distributors and looks for similar characteristics of such behaviour. The goalof this article is to analyze current pharmaceutical market in relation with regulated prices and on this basis to describe optimal profit margin on this market. Today's economy results from more or less theoretical findings that cannot

Název v anglickém jazyce

Pharmaceutical Price Regulation in the Theory of Redistribution Systems

Popis výsledku anglicky

Nowadays, a firm has to, not only, follow the outside environment and predominantly its field environment where it constantly maps customers' behaviour, but the firm has to also perceive the inside environment. Firm price making represents the key role.This paper describes pharmaceutical market and its rules of price making. As remedies should be available to anyone, it is obvious that the market is regulated by state. Products are divided into groups according to their prices. The groups are identified by the highest possible percentage of margin that can be made by a particular product. On the basis of publicly available data this paper analyses behaviour of producers and distributors and looks for similar characteristics of such behaviour. The goalof this article is to analyze current pharmaceutical market in relation with regulated prices and on this basis to describe optimal profit margin on this market. Today's economy results from more or less theoretical findings that cannot

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

AH - Ekonomie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Acta academica karviniensia

ISSN

1212-415X

e-ISSN

—

Svazek periodika

2014

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

9

Strana od-do

149-157

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—